(Q46502407)

22 December 2017

title

Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant glioma (English)

1 reference

22 December 2017

1 reference

8

Mark C Preul

1 reference

22 December 2017

Tejas Sankar

1

1 reference

22 December 2017

Zografos Caramanos

2

1 reference

22 December 2017

Rachid Assina

3

1 reference

22 December 2017

Jean-Guy Villemure

4

1 reference

22 December 2017

Richard Leblanc

5

1 reference

22 December 2017

Adrian Langleben

6

1 reference

22 December 2017

Douglas L Arnold

7

1 reference

22 December 2017

publication date

4 July 2008

1 reference

22 December 2017

Journal of Neuro-Oncology

published in

1 reference

22 December 2017

volume

90

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

page(s)

63-76

1 reference

22 December 2017

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Management of malignant glioma: steady progress with multimodal approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Magnetic resonance spectroscopic imaging. Evaluating responses to therapy for gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Neuroimaging in glioma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Selective oestrogen receptor modulators/new antioestrogens: a clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Inhibition of protein kinase C mediated signal transduction by tamoxifen. Importance for antitumour activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Inhibition of growth of established human glioma cell lines by modulators of the protein kinase-C system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Distribution of tamoxifen and metabolites into brain tissue and brain metastases in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

The treatment of intracranial malignant gliomas using orally administered tamoxifen therapy: preliminary results in a series of "failed" patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Salvage chemotherapy with tamoxifen for recurrent anaplastic astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Volume MRI and MRSI techniques for the quantitation of treatment response in brain tumors: presentation of a detailed case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Variation of post-treatment H-MRSI choline intensity in pediatric gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Proton magnetic spectroscopic imaging of the child's brain: the response of tumors to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Multisection 1H magnetic resonance spectroscopic imaging assessment of glioma response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Chemotherapy for the treatment of oligodendroglial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Serial evaluation of patients with brain tumors using volume MRI and 3D 1H MRSI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

MR-spectroscopy guided target delineation for high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

In vivo 1H MRS choline: correlation with in vitro chemistry/histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Automated classification of short echo time in in vivo 1H brain tumor spectra: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Could assessment of glioma methylene lipid resonance by in vivo (1)H-MRS be of clinical value?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Protein kinase C inhibitors suppress cell growth in established and low-passage glioma cell lines. A comparison between staurosporine and tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Fluorescent in situ hybridization and ex vivo 1H magnetic resonance spectroscopic examinations of meningioma tumor tissue: is it possible to identify a clinically-aggressive subset of benign meningiomas?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9632-3

Treatment of brain tumors in children is associated with abnormal MR spectroscopic ratios in brain tissue remote from the tumor site

21 January 2018

1 reference

12 December 2020

Protein kinase C and growth regulation of malignant gliomas.

1 reference

12 December 2020

Recurrent glioblastoma multiforme: a review of natural history and management options

1 reference

12 December 2020

Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery

1 reference

12 December 2020

Effect of tamoxifen on DNA synthesis and proliferation of human malignant glioma lines in vitro.

1 reference

12 December 2020

Treatment of recurrent malignant gliomas with chronic oral high-dose tamoxifen.

1 reference

12 December 2020

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

12 December 2020

Prognostic significance of serial magnetic resonance spectroscopies over the course of radiation therapy for patients with malignant glioma

1 reference

12 December 2020

Pitfalls in lactate measurements at 3T.

1 reference

12 December 2020

3T 1H-MR spectroscopy in grading of cerebral gliomas: comparison of short and intermediate echo time sequences.

1 reference

12 December 2020

Procarbazine and high-dose tamoxifen as a second-line regimen in recurrent high-grade gliomas: a phase II study

1 reference

12 December 2020

The relationship between nuclear magnetic resonance-visible lipids, lipid droplets, and cell proliferation in cultured C6 cells

1 reference

12 December 2020

Chemotherapy for high-grade glioma

1 reference

12 December 2020

Inhibition of protein kinase C by tamoxifen

1 reference

12 December 2020

Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas.

1 reference

12 December 2020

10.1007/S11060-008-9632-3

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017